Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading Up 0% – Still a Buy?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) shares rose 0% during trading on Wednesday . The company traded as high as $10.78 and last traded at $10.7810. 3,538 shares traded hands during trading, a decline of 86% from the average daily volume of 26,110 shares. The stock had previously closed at $10.78.

Analysts Set New Price Targets

Separately, Weiss Ratings raised Oaktree Acquisition Corp. III Life Sciences from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, August 13th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Stock Up 0.2%

The stock has a fifty day moving average price of $10.73 and a 200-day moving average price of $10.69.

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) last announced its quarterly earnings data on Wednesday, August 12th. The company reported $0.07 earnings per share (EPS) for the quarter.

Institutional Trading of Oaktree Acquisition Corp. III Life Sciences

A number of institutional investors have recently added to or reduced their stakes in the stock. Millennium Management LLC acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth $4,848,000. Goldman Sachs Group Inc. acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter valued at $5,417,000. JPMorgan Chase & Co. purchased a new position in Oaktree Acquisition Corp. III Life Sciences during the second quarter worth $2,094,000. Whitebox Advisors LLC acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the second quarter worth $2,612,000. Finally, Lighthouse Investment Partners LLC lifted its position in shares of Oaktree Acquisition Corp. III Life Sciences by 88.9% in the second quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company’s stock valued at $8,882,000 after acquiring an additional 400,000 shares in the last quarter.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.